UNIGE document Scientific Article
previous document  unige:85251  next document
add to browser collection

Biodegradable scleral implants as new triamcinolone acetonide delivery systems

Eperon, S.
Mora, P.
Limal, D.
Sagodira, S.
Breton, P.
Simonazzi, B.
show hidden authors show all authors [1 - 10]
Published in International Journal of Pharmaceutics. 2006, vol. 322, no. 1-2, p. 6-12
Abstract The goal of this study was to develop ocular scleral implants able to release triamcinolone acetonide (TA) overall several months. Scleral discs were manufactured by a compression-molding method using a new synthetic polymer, poly(methylidene malonate) (PMM2.1.2), as matrix. Implants with good mechanical properties adapted for in vivo implantation have been obtained when using high M(w) PMM2.1.2 (100,000 - 150,000 Da) associated with ethoxylated derivatives of stearic acid (Simulsol) or oligomers of methylidene malonate as plasticizer. After implantation in rabbit eyes, scleral implants showed a good ocular biocompatibility. Indeed, the clinical follow-up and ocular inflammation parameters, such as inflammatory cell number and protein content in aqueous humor, demonstrated that implants were well tolerated and did not provoke abnormal inflammation. Implants were able to release significant concentrations of TA in the vitreous and the sclera throughout 5 weeks.
Keywords Scleral implantBiodegradable polymerBiocompatibilityTriamcinolone acetonide
PMID: 16824708
Full text
Article (Published version) (218 Kb) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
FELT-BAEYENS, Olivia et al. Biodegradable scleral implants as new triamcinolone acetonide delivery systems. In: International Journal of Pharmaceutics, 2006, vol. 322, n° 1-2, p. 6-12. doi: 10.1016/j.ijpharm.2006.05.053 https://archive-ouverte.unige.ch/unige:85251

256 hits

1 download


Deposited on : 2016-07-13

Export document
Format :
Citation style :